EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC

Mengyuan Li, Shuwen Zheng, Qinyuan Gong, Zhaoxing Wu, Wen Lei, Wanyue Cao, Ping Wang, Xuzhao Zhang, Wenbin Qian, Yun Liang, Ying Lu, Fenglin Li und 2 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202417432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mengyuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Secon…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Tumor Escape. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Research Plan of the National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8 + T cell anergy is a critical driver of cancer immune evasion, but the underlying causes and mechanisms remain elusive. Here, the functional human endogenous retroviruses‐K envelope (HERV‐K Env) subunit transmembrane (K‐TM) is identified as a potent viral immune checkpoint that induces CD8 + T cell anergy and elicits immune evasion in acute myeloid leukemia (AML) and pancreatic duct adenocarcinoma (PDAC). K‐TM subunits are highly expressed in CD8 + T cells and enriched in sera of cancer patients. K‐TM‐low CD8 + T cells show potent tumor‐killing ability, whereas K‐TM‐high CD8 + T cells are incapable of eliciting anti‐tumor effects. Both intracellular and extracellular K‐TM inhibit CD8 + T cell activation and cytokine release, leading to CD8 + T cell anergy. Mechanistically, K‐TM directly binds to the ITAM domain of CD3ε receptor via its transmembrane domain (TMD), inhibiting CD3ε phosphorylation and disabling TCR signaling. In mouse models, K‐TM reduces CD8 + T cell infiltration in tumor tissues and elicits immune evasion. Targeting K‐TM reverses CD8 + T cell anergy, restores T cell‐mediated tumor cell killing and regresses PDAC in animal model. The findings for the first time define viral immune checkpoint K‐TM subunit as potent driving force of immune evasion and represent a conceptually new target for immune therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesPancreatic NeoplasmsCarcinoma, Pancreatic DuctalTumor EscapeLeukemia, Myeloid, AcuteEndogenous RetrovirusesCD3 ComplexAnimalsMiceHumansCell Line, Tumor

Stichwörter der Autor:innen

AMLCD3εCD8+ T cell anergyHERV‐KPDACVICsimmune evasion

Substanzen

CD3 Complex

Autor:innen und Institutionen

  • Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzho…
  • Institute of Hematology, Zhejiang University, Hangzhou, 310009, China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • MOE Joint International Research Laboratory of Pancreatic Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
  • Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, 315000, China.

ORCID-Profile: Rongzhen Xu

Förderung

  • National Natural Science Foundation of China
  • Major Research Plan of the National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Li, M., Zheng, S., Gong, Q., Wu, Z., Lei, W., Cao, W., Wang, P., Zhang, X., Qian, W., Liang, Y., Lu, Y., Li, F., Zhang, Q., & Xu, R. (2026). HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC. Advanced Science. https://doi.org/10.1002/advs.202417432

Vancouver

Li M, Zheng S, Gong Q, Wu Z, Lei W, Cao W, et al. HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC. Advanced Science. 2026. doi:10.1002/advs.202417432

BibTeX
@article{Li2026,
  author = {Li, Mengyuan and Zheng, Shuwen and Gong, Qinyuan and Wu, Zhaoxing and Lei, Wen and Cao, Wanyue and Wang, Ping and Zhang, Xuzhao and Qian, Wenbin and Liang, Yun and Lu, Ying and Li, Fenglin and Zhang, Qi and Xu, Rongzhen},
  title = {HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202417432}
}
Kostenlos starten →